John Rogers Invests in Bristow Group, Kindred Biosciences

Guru boosts Bristow stake by 24%

Author's Avatar
Apr 08, 2016
Article's Main Image

John Rogers (Trades, Portfolio), founder of Ariel Investment LLC, added to two stakes in his portfolio – Bristow Group Inc. (BRS, Financial) and Kindred Biosciences Inc. (KIN, Financial) – on March 31.

The guru raised his stake in Bristow Group, a British helicopter services provider, nearly 24% with the acquisition of 1,895,773 shares for $18.92 per share. The deal had a 0.43% impact on Rogers’ portfolio.

Rogers’ stake, now 9,801,510 shares, is 28.04% of Bristow Group’s outstanding shares and 2.21% of Rogers’ total assets. Rogers is Bristow Group’s leading shareholder among the gurus.

Bristow Group has a P/B of 0.4 and a P/S of 0.4. GuruFocus gives Bristow Group a Financial Strength rating of 6/10 and a Profitability and Growth rating of 6/10.

02May2017171639.png

Bristow Group sold for $18.34 per share Friday afternoon.

Rogers boosted his stake in Kindred Biosciences, a Burlingame, California-based biopharmaceutical company focusing on medical therapies for dogs, cats and horses, by nearly 44% with the purchase of 1,089,382 shares for $3.45 per share. The transaction had a 0.05% impact on Rogers’ portfolio.

Rogers’ stake, now 3,587,561 shares, is 18.08% of Kindred Biosciences’ outstanding shares and 0.15% of Rogers’ total assets. Rogers is Kindred Biosciences’ leading shareholder among the gurus.

Kindred Biosciences has a P/B of 1. GuruFocus gives Kindred Biosciences a Financial Strength rating of 7/10 and a Profitability and Growth rating of 3/10.

Kindred Biosciences sold for $3.78 per share Friday afternoon.

To view the gurus' latest stock picks, visit the Real Time Stock Picks page. Not a premium member of GuruFocus? Try it free for seven days.